| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Ft24.85 |
| 52 Week High | Ft25.95 |
| 52 Week Low | Ft23.55 |
| Beta | 0.39 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 328.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| GEDS.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -3.7% |
| 1Y | n/a | 11.4% | 20.2% |
Return vs Industry: Insufficient data to determine how GEDS.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how GEDS.F performed against the US Market.
Price Volatility
| GEDS.F volatility | |
|---|---|
| GEDS.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GEDS.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GEDS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1901 | 11,603 | Gabor Orban | www.gedeonrichter.com/hu-hu |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Fundamentals Summary
| GEDS.F fundamental statistics | |
|---|---|
| Market cap | US$4.49b |
| Earnings (TTM) | US$431.28m |
| Revenue (TTM) | US$2.19b |
10.4x
P/E Ratio2.1x
P/S RatioIs GEDS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GEDS.F income statement (TTM) | |
|---|---|
| Revenue | Ft805.16b |
| Cost of Revenue | Ft283.83b |
| Gross Profit | Ft521.32b |
| Other Expenses | Ft362.47b |
| Earnings | Ft158.85b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 869.11 |
| Gross Margin | 64.75% |
| Net Profit Margin | 19.73% |
| Debt/Equity Ratio | 6.0% |
How did GEDS.F perform over the long term?
See historical performance and comparison